Table 2 Outcomes after receiving study treatment
misoprostol | placebo | ||
|---|---|---|---|
n = 29 | n = 32 | RR [95% CI] or p-value | |
Postpartum blood loss after study treatment | |||
(n = 27) ^ | (n = 32) | ||
Total blood loss post-treatment (ml) | |||
mean ± sd | 175 ± 168 | 187 ± 207 | p = .809 |
Range | 10–700 | 10–900 | |
Blood loss ≥ 500 ml post-treatment %(n) | 7.4 (2) | 12.5 (4) | .59 [.12, 2.99] |
Postpartum hemoglobin measures | |||
Post-delivery Hb | |||
mean ± sd | 9.0 ± 1.4 | 8.7 ± 1.2 | p = .291 |
range | 5.9 – 11.3 | 5.9 – 10.2 | |
Drop in Hb | |||
mean ± sd | 2.0 ± 1.1 | 2.2 ± 1.4 | p = .614 |
range | 0.4 – 4.2 | 0.1 – 5.1 | |
Postpartum Hb ≥ 2 g/dL lower than pre-delivery Hb %(n) | 41.4 (12) | 56.3 (18) | .74 [.43, 1.25] |
Additional interventions | |||
Amount of IV fluids given | |||
500–1000 ml | 75.9 (22) | 53.1 (17) | |
> 1000 ml | 24.1 (7) | 46.9 (15) | .51 [.24, 1.08] |
Blood transfusion %(n) | 17.2 (5) | 18.8 (6) | .92 [.31, 2.69] |
Uterine packing %(n) | 6.9 (2) | 18.8 (6) | .37 [.08, 1.68] |
Balloon tamponade %(n) | 0.0 (0) | 3.1 (1) | .00 [.00, 43.0] |
Referrals for additional PPH care %(n) | 3.4 (1) | 3.2 (1) | 1.1 [.07, 16.9] |